Categories Earnings, LATEST, Technology
STMicroelectronics stock tanks on weak outlook, despite Q3 beat
Shares of semiconductor firm STMicroelectronics (STM) plunged more than 10% Wednesday after its fourth-quarter guidance fell short of estimates, despite the company reporting strong revenue and earnings growth for the third quarter. The weak quarterly sales posted by fellow chipmaker Texas Instruments earlier this week had added to the slump in investor sentiment over the faltering chip market.
STM’s net income increased to $369 million or $0.41 per share from $236 million or $0.26 per share in the prior-year quarter, exceeding the forecast. Gross margin moved up 20 basis points to 39.8% during the third quarter.
At $2.52 billion, revenues were 18% higher compared to the third quarter of 2017, with significant contribution from the Analog, MEMS & Sensors segment that registered a 36.7% growth. The top-line came in slightly above the market’s prediction. Revenues of Automotive & Discrete and Microcontrollers & Digital ICs were up 16.3% and 2.5% respectively.
STM’s week guidance added to the concerns over the softness in the chip market and triggered a selloff
Looking ahead, the company expects full-year 2018 revenues to be up 16% year-over-year. It is looking for gross margins of 39.8% in the fourth quarter when revenues are estimated to grow about 5.7%. The guidance, meanwhile, falls short of the consensus estimate.
“Based on our fourth quarter guidance, we anticipate 2018 revenues to grow about 16% year-over-year, in line with our expectations shared in May at our Capital Markets Day. This level of revenue growth will also drive strong improvements in operating margin and net earnings,” said CEO Jean-Marc Chery.
Texas Instruments (TXN) witnessed a selloff Tuesday after its third-quarter sales missed estimates. Meanwhile, the company’s earnings surged 25% to $1.58 per share aided by lower expense and a favorable income tax provision.
STMicroelectronics’ shares plunged about 40% over the past twelve months. They have been on a downward spiral after reaching a peak in June this year. The stock fell sharply Wednesday after the earnings report.
Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on